April Journal-2009.p65 - Association of Biotechnology and Pharmacy
April Journal-2009.p65 - Association of Biotechnology and Pharmacy
April Journal-2009.p65 - Association of Biotechnology and Pharmacy
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Current Trends in <strong>Biotechnology</strong> <strong>and</strong> <strong>Pharmacy</strong><br />
Vol. 3 (2) <strong>April</strong> 2009. ISSN 0973-8916<br />
Table 1. Composition <strong>of</strong> levodopa <strong>and</strong> carbidopa (200mg+50mg) controlled release tablet formulations<br />
Each 400mg LDCD CR formulation contains 0.025% Brilliant blue, 0.1% Ascorbic acid, 0.625% Talc, 0.625%<br />
Aerosil. MCC: Microcrystalline cellulose, LDCD CR: Levodopa Carbidopa Controlled Release.<br />
Table: 2<br />
Micromeritic properties <strong>of</strong> drugs (levodopa <strong>and</strong> carbidopa)<br />
Jagan et al